Aurobindo sets base for US OTC flurry via Natrol deal
This article was originally published in Scrip
Executive Summary
Shares of Aurobindo Pharma moved up firmly on Indian bourses on 12 November after the company said that its US arm had emerged as the top bidder for nutritional supplements provider Natrol and its affiliates.